Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I

Nature Genetics

Volumn 19, Issue 3, 1998, Pages 279-281

  Geller, David S ^a   Rodriguez Soriano, Juan ^c   Vallo Boado, Alfredo ^c   Schifter, Søren ^d   Bayer, Milan ^e   Chang, Sue S ^a   Lifton, Richard P ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL DE CRUCES   (Spain)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

MINERALOCORTICOID RECEPTOR;

ALLELE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GENE MUTATION; HUMAN; HYPERKALEMIA; HYPOTENSION; METABOLIC ACIDOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; RECEPTOR GENE; SALT LOSING NEPHRITIS; SODIUM BALANCE;

BASE SEQUENCE; DNA, COMPLEMENTARY; FEMALE; FRAMESHIFT MUTATION; GENES, DOMINANT; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PSEUDOHYPOALDOSTERONISM; RECEPTORS, MINERALOCORTICOID; VARIATION (GENETICS);

EID: 0031861245     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/966     Document Type: Article

References (24)

1. Kuhnle, U. Pseudohypoaldosteronism: mutation found, problem solved? Mol. Cell. Endocrinol. 133, 77-80 (1997).
2. Chang, S.S. et al. Mutations in subunits of the epithelial sodium channel cause salt-wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nature Genet. 12, 248-253 (1996).
3. Strautnieks, S.S., Thompson, R.J., Gardiner, R.M. & Chung, E. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type I families. Nature Genet. 13, 248-250 (1996).
4. Grunder, S. & Rossier, B. A reappraisal of aldosterone effects on the kidney: new insights provided by epithelial sodium channel cloning. Cure Opin. Nephrol. Hypertens. 6, 35-39 (1997).
5. Beato, M. Gene regulation by steroid hormones. Cell 56, 335-344 (1989).
6. Shapiro, M.B. & Senapathy, P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 15, 7155-7174 (1987).
7. Krawczak, M., Reiss, J. & Cooper, D.N. The mutational spectrum of single base-pair substitutions. in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90, 41-54 (1992).
8. Berger, S., Cole, T.J., Schmid, W. & Schütz, G. Analysis of glucocorticoid and mineralocorticoid signalling by gene targeting. Endocr. Res. 22, 641-652 (1996).
9. Zennaro, M.C., Borensztein, P., Jeunemaitre, X., Armanini, D. & Soubrier, F. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J. Clin. Endocrinol. Metab. 79, 32-38 (1994).
10. Komesaroff, P.A., Verity, K. & Fuller, P.J. Pseudohypoaldosteronism: molecular characterization of the mineralocorticoid receptor. J. Clin. Endocrinol. Metab. 79, 27-31 (1994).
11. Arai, K. et al. No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism. J. Clin. Endocrinol. Metab. 80, 814-817 (1995).
12. Pascoe, L., Curnow, K.M., Slutsker, L., Rosler, A. & White, P.C. Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyl-oxidase II deficiency. Proc. Natl Acad Sci. USA 89, 4996-5000 (1992).
13. Rosler, A. The natural history of salt-wasting disorders of adrenal and renal origin. J. Clin. Endocrinol. Metab. 59, 689-700 (1984).
14. Koo, W.W. & Gupta, J.M. Breast milk sodium. Arch. Dis. Child. 57, 500-502 (1982).
15. Sippell W.G., Dorr, H.G., Bidlingmaier F. & Knorr, D. Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, Cortisol, and cortisone during infancy and childhood. Ped. Res. 14, 39-46 (1980).
16. + absorption in human rectum in vitro. Am. J. Physiol. 269, G42-G48 (1995).
17. Gomez-Sanchez, E.P., Zhou, M. & Gomez-Sanchez, C.E. Mineralocorticoids, salt and high blood pressure. Steroids 61, 184-188 (1996).
18. Rodriguez-Soriano, J., Ubetagoyena, M. & Vallo, A. Transtubular potassium concentration gradient: a useful test to estimate renal aldosterone bio-activity in infants and children. Ped. Nephrol. 4, 105-110 (1990).
19. Bayer, M. & Kutilek, S. A hereditary form of pseudohypoaldosteronism may be manifested in the course of pyelonephritis. Acta Paed. 82, 504 (1993).
20. Petersen, S. et al. Pseudohypoaldosteronism. case report. Acta Paediatr. Scand. 67, 255-261 (1978).
21. Zennaro, M.C. et al. Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J. Biol. Chem. 270, 21016-21020 (1995).
22. Shimkets, R.A. et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79, 407-414 (1994).
23. Hansson, J.H. et al. A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle's syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc. Natl Acad. Sci. USA 92, 11495-11499 (1995).
24. Lim-Tio, S.S., Keightley, M.C. & Fuller, P.J. Determinants of specificity of transactivation in the mineralocorticoid or glucocorticoid receptor. Endocrinology 138, 2537-2543 (1997).